The Latest Breaking News from Seabreeze

Connect Biopharma Touts Rademikibart’s Edge as SEABREEZE Data Looms in 2026

Connect Biopharma (NASDAQ:CNTB) Chief Executive Officer Barry Quart said the company’s rademikibart program continues to show a differentiated clinical and mechanistic profile as the company awaits mid-2026 data from its SEABREEZE study. Speaking during a fireside chat with H.C. Wainwright analyst

MarketBeat · May 22

More than 1.5 million dehumidifiers recalled after fire and burn reports

Including brands such as Kenmore, GE, SoleusAir, Norpole and Seabreeze

T3 · Aug 18, 2023

Over 1,500,000 dehumidifiers recalled due to fire risk — check if yours is affected

Over 1.5m dehumidifiers from 5 brands have been recalled after fire risk.

Tom’s Guide · Aug 18, 2023